Quality Control Strategy for Vaccine Development - Rapid Response Strategies
Vaccines represent a diverse class of products within the pharmaceutical industry. All are complex and present their own unique challenges not only in production but in the design and implementation of strategic characterisation and quality control programs. The highest levels of safety and efficacy should be ensured through application of phase specific validated analytical methods.
In this webinar, our expert, Ashleigh Wake, describes how to build strategic quality control programs which are product and phase specific covering the need for specialist, bespoke analytical approaches for highly complex products.
Complete the form below to listen to the webinar